Groowe Groowe / Newsroom / TVRD
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TVRD News

Tvardi Therapeutics, Inc. Common Stock

Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update

businesswire.com
TVRD

Tvardi Therapeutics, Inc. (TVRD) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today

accessnewswire.com
TVRD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD

accessnewswire.com
TVRD

Investigation Opened on Behalf of Tvardi Therapeutics, Inc. (TVRD) Shareholders - Contact Levi & Korsinsky

accessnewswire.com
TVRD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD

accessnewswire.com
TVRD

Levi & Korsinsky Investigating Whether Tvardi Therapeutics, Inc. (TVRD) Misled Investors - Securities Law Violations Possible

accessnewswire.com
TVRD

ATTENTION TVRD Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky

accessnewswire.com
TVRD

Tvardi Therapeutics, Inc. (TVRD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

accessnewswire.com
TVRD

Levi & Korsinsky Investigates Tvardi Therapeutics, Inc. (TVRD) Over Possible Securities Fraud

accessnewswire.com
TVRD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tvardi Therapeutics, Inc. - TVRD

accessnewswire.com
TVRD